Tildrakizumab (Anti-IL-23a)
Tildrakizumab (Anti-IL-23a) is a humanized monoclonal antibody directed against the p19 protein subunit of interleukin-23 (IL-23), with immunomodulating activity. MW:145.5 KD.
Trivial name | SCH 900222, MK 3222 |
Catalog Number | A2437 |
CAS# | 1326244-10-3 |
Size | 1mg*5 |
Supplier Page | http://www.selleckchem.com/products/tildrakizumab-anti-il-23a.html |